News Archive

SomaLogic signs collaborative agreement with Novo Nordisk to support drug development efforts

SomaLogic, Inc., a global leader in proteomics technology, announced today that it is adding to its list of collaborative agreements with global healthcare innovator, Novo Nordisk. As part of the agreement, Novo Nordisk will expand the use of the SomaScan® technology platform for their drug development research in non-alcoholic steatohepatitis (NASH), cardiovascular disease and diabetes.

read more

New study shows consistency in proteogenomic signals between proteomic measurement platforms

Researchers at the University of Cambridge report the largest, systematic assessment of two different affinity-based proteomic platform technologies to date. By truncating the 5000-plex aptamer-based SomaScan® Assay results down to consider approximately 900 overlapping targets on a polyclonal antibody-based assay and running both assays on the same 485 genotyped samples, the researchers successfully replicated most proteogenomic signals on both platforms.

read more

SomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology Platform

SomaLogic and CM Life Sciences II (NASDAQ: CMIIU), a special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, today announced that they have entered into a definitive business combination agreement. Upon closing of the transaction CM Life Sciences II will be renamed and its common stock will be listed on the Nasdaq Global Market under ticker symbol “SLGC.”

read more

SomaLogic Announces Customizable Protein Panels

SomaLogic, Inc., a global leader in proteomics technology, announced today its intention to broaden its proteomics offerings to pharma, biotechnology and academic research customers by adding smaller protein measurement panel products to its market-leading, large-plex offering.

read more

SomaLogic Expands Its Commercial Capabilities with Three New Senior Leaders

SomaLogic Inc. announced today the appointments of Angela Bakker Lee, Ph.D. as executive vice president for healthcare markets, Tracy Hervey, MBA as executive vice president for life sciences markets and David McGovern, MBA as senior vice president of marketing. In these roles, Dr. Bakker Lee, Ms. Hervey and Mr. McGovern will drive business development and marketing efforts for SomaLogic’s proprietary protein measurement technology and growing portfolio of protein-based health information products.

read more